Supernus Pharmaceuticals | SUPN - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 758.17M 22.16M 2025-12
Cara Therapeutics USD 27.87M 5.06M 2025-09
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Novo Nordisk DKK 194.05B 24.15B 2025-12
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12